Commissioner of human services authorized to provide separate reimbursement for biological products provided in the inpatient hospital setting as part of cell or gene therapy to treat rare diseases.
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2024
Committee Review
Floor Vote
Governor
Introduced Feb 13, 2024
Last action Mar 18, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
4
Key actions
0
Committee
0
Feb 13, 2024
Introduced
Introduction and first reading, referred to Health Finance and Policy
lower
1 primary · 3 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HF 3664
Scope: MN
Hi! I can help you understand HF 3664. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline